Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers April 26, 2018
Pharmacy Choice - Pharmaceutical News - NDI Notification Practical: How to Submit an NDI Notification Without Objection - April 26, 2018

Pharmacy News Article

 4/13/17 - NDI Notification Practical: How to Submit an NDI Notification Without Objection

SILVER SPRING, Md., April 11 The American Herbal Products Association issued the following news release:

Section 413 of the Federal Food, Drug and Cosmetic Act (FD&C Act) requires the manufacturer or distributor of a New Dietary Ingredient (NDI), or of a dietary supplement containing the NDI, to submit a premarket notification to the Food and Drug Administration (FDA) at least 75 days before introducing the NDI or dietary supplement into interstate commerce, unless the NDI and any other ingredients in the dietary supplement have been present in the food supply as an article used for food in a form in which the food has not been chemically altered. The notification must contain in the information, including any citation to published articles, which is the manufacturer or distributor's basis for concluding that a dietary supplement containing the NDI will reasonably be expected to be safe. In August 2016, FDA announced the availability of a revised draft guidance for NDIs that superseded the July 2011 draft guidance. The dietary supplement industry and FDA share the goal of ensuring that NDI notifications, when required, are clearly presented and thorough in providing safety information to FDA as required by law.

As such, the American Herbal Products Association (AHPA) has created the AHPA NDI Database, a searchable online resource that documents more than 800 NDI notifications that have been submitted to FDA. This database provides indispensable access to and understanding of notifications submitted to FDA for new NDIs that are used in dietary supplements. It is the only up-to-date compilation of NDI notifications available. This subscriber-based database also provides a concise "outcome statement" for each NDI file that quickly summarizes how FDA has responded to every notification, and the problemsif anythat the agency identified for each.

Dr. Ali Abdel-Raman, supervisory toxicologist at CFSAN / FDA, will be on hand to discuss FDA's views on the procedures for submitting an NDI notification; the types of data and information that manufacturers and distributors should consider when evaluating the safety of a dietary supplement containing an NDI; and what should be included in an NDI notification. Michael McGuffin, AHPA's president, will provide a tour and demonstration of AHPA's NDI Database. Dr. Claire L. Kruger, president, Spherix Consulting, a division of ChromaDex, Inc., will provide real world experience after having filed an NDI notification that was met with objections by FDA, and then successfully addressed FDA's observations when resubmitting the NDI notification without objections.

Attend this webinar to learn how to successfully traverse the NDI notification process and avoid common pitfalls that can result in FDA objections.


* Ali Abdel-Rahman, Ph.D., Supervisory Toxicologist, Center for Food Safety and Applied Nutrition (CFSAN), Food and Drug Administration (FDA)

* Claire L. Kruger, Ph.D., D.A.B.T., President, Spherix Consulting, a division of ChromaDex, Inc.

* Michael McGuffin, President, American Herbal Products Association (AHPA)

* Will Woodlee, Esq., Partner, Kleinfeld, Kaplan and Becker, LLP (Q&A Only)

Targeted News Service

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Last Chance
Apr 26: The Immunity Puzzle- The Balance of Stress, Inflammation with Lifestyle Medicine
Apr 29: Metabolic Syndrome: The Heart of Any Wellness Practice
Apr 30: Legal & Practical Issues in Compounding Pharmacy
May 01: Medication Use During Pregnancy & Lactation
May 02: Using Effective Communication to Reduce Medication Errors
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement